PT  - JOURNAL ARTICLE
AU  - Rolig, Annah S
AU  - Rose, Daniel C
AU  - McGee, Grace Helen
AU  - Rubas, Werner
AU  - Kivimäe, Saul
AU  - Redmond, William L
TI  - Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8<sup>+</sup> T cell cytotoxicity over BEMPEG+RT
AID  - 10.1136/jitc-2021-004218
DP  - 2022 Apr 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e004218
VI  - 10
IP  - 4
4099  - http://jitc.bmj.com/content/10/4/e004218.short
4100  - http://jitc.bmj.com/content/10/4/e004218.full
SO  - J Immunother Cancer2022 Apr 01; 10
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.